Quick Takeaways
- Enavate Sciences GP, LLC filed SCHEDULE 13D/A for IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM).
- Disclosed ownership: 4.3%.
- Date of event: 18 Dec 2025.
Enavate Sciences GP, LLC - 18 Dec 2025 SCHEDULE 13D/A Report for IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM)
- Filing Manager
- Enavate Sciences GP, LLC
- Reporting Manager
- Enavate Sciences GP, LLC
- Symbol
- IMNM
- Shares outstanding
- 110,897,279 shares
- Disclosed Ownership
- 4,768,583 shares
- Ownership
- 4.3%
- Form type
- SCHEDULE 13D/A
- Filing time
- 22 Dec 2025, 21:22:47 UTC
- Date of event
- 18 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Enavate Sciences GP, LLC disclosed 4.3% ownership in IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM) on 18 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Dec 2025, 21:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 4.3% | 4,768,583 | 0 | 4,768,583 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |
| Immunome Aggregator, LP | 4.3% | 4,768,583 | 0 | 4,768,583 | /s/ James P. Boylan | By Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0001996276 |